Literature DB >> 2319140

Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactors.

R A Knazek1, Y W Wu, P M Aebersold, S A Rosenberg.   

Abstract

Human tumor infiltrating lymphocytes (TIL) from metastatic melanoma of six patients were grown using a new hollow fiber bioreactor system. After inoculating 0.35-10 X 10(8) TIL into the extra-fiber space (EFS), each Cellmax bioreactor was perfused with AIM-V medium, supplemented with rIL-2. The cells subsequently expanded 124-1170-fold to yield 1.5-5.4 X 10(10) TIL over a 14-32 day period. TIL were flushed from the EFS using 200 ml medium and possessed an average viability = 91%. The phenotype and the autologous tumor cell lytic capacity of these TIL were similar to those of TIL grown in the currently used gas-permeable culture bags. Tissue culture media use averaged 4.3 liters/10(10) TIL harvested. The TIL of one patient were re-expanded twice from cells remaining within the same bioreactor after harvest suggesting that one bioreactor cartridge could be used for repetitive, periodic studies. An estimated 80% decrease in technical time expended and in incubator space requirements were realized using this methodology. Cell culture on hollow fibers appears to be a useful method for producing large quantities of primary human lymphocytes for experimental, and perhaps, therapeutic needs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319140     DOI: 10.1016/0022-1759(90)90337-u

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex).

Authors:  Juan F Vera; Lara J Brenner; Ulrike Gerdemann; Minhtran C Ngo; Uluhan Sili; Hao Liu; John Wilson; Gianpietro Dotti; Helen E Heslop; Ann M Leen; Cliona M Rooney
Journal:  J Immunother       Date:  2010-04       Impact factor: 4.456

2.  Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy.

Authors:  Jacob A Klapper; Armen A Thomasian; Douglas M Smith; Gayle C Gorgas; John R Wunderlich; Franz O Smith; Brian S Hampson; Steven A Rosenberg; Mark E Dudley
Journal:  J Immunol Methods       Date:  2009-04-21       Impact factor: 2.303

3.  Comparison of cell growth in T-flasks, in micro hollow fiber bioreactors, and in an industrial scale hollow fiber bioreactor system.

Authors:  M J Gramer; D M Poeschl
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

4.  Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment.

Authors:  Jianjian Jin; Marianna Sabatino; Robert Somerville; John R Wilson; Mark E Dudley; David F Stroncek; Steven A Rosenberg
Journal:  J Immunother       Date:  2012-04       Impact factor: 4.456

Review 5.  Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.

Authors:  Ann M Leen; Tamara Tripic; Cliona M Rooney
Journal:  Expert Opin Biol Ther       Date:  2010-03       Impact factor: 4.388

6.  Reduced expression of distinct T-cell CD molecules by collagenase/DNase treatment.

Authors:  W M Mulder; H Koenen; A J van de Muysenberg; E Bloemena; J Wagstaff; R J Scheper
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

Review 7.  Human autologous tumor-specific T cells in malignant melanoma.

Authors:  C D Platsoucas
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

8.  Studies on the use of hollow fibre membrane bioreactors for tissue generation by using rat bone marrow fibroblastic cells and a composite scaffold.

Authors:  Hua Ye; Zhidao Xia; David J P Ferguson; James T Triffitt; Zhanfeng Cui
Journal:  J Mater Sci Mater Med       Date:  2007-04       Impact factor: 3.896

9.  Bioprocess development for the cultivation of human T-lymphocytes in a clinical scale.

Authors:  H Bohnenkamp; U Hilbert; T Noll
Journal:  Cytotechnology       Date:  2002-01       Impact factor: 2.058

10.  Optimizing the production of suspension cells using the G-Rex "M" series.

Authors:  Pradip Bajgain; Roopa Mucharla; John Wilson; Dan Welch; Usanarat Anurathapan; Bitao Liang; Xiaohua Lu; Kyle Ripple; John M Centanni; Christine Hall; David Hsu; Larry A Couture; Shubhranshu Gupta; Adrian P Gee; Helen E Heslop; Ann M Leen; Cliona M Rooney; Juan F Vera
Journal:  Mol Ther Methods Clin Dev       Date:  2014-05-14       Impact factor: 6.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.